Recreating key features of the antibody factory in a dish
FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
New data from DM1 study
Synaptiq Therapeutics launches with acquisition of SYN-001 programme
Collaboration to develop first medicine for newly identified ReNU syndrome
Body’s natural recycling system could help reduce inflammation
Crystalys Therapeutics raises $130m for gout treatment
Boost to biotech in Virginia with lab capacity increase
AI and sleep analysis help early diagnosis of Alzheimer’s
Taiwan positions itself as global biotech innovation partner at BIO Asia-Taiwan 2026